Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement factor H-related protein 4 (CFHR4) is a member of the CFH family, comprising five closely linked genes encoding secreted plasma proteins primarily synthesized in the liver. CFHR4 contains several short consensus repeats (SCRs) and modulates complement activation by binding C3b and other ligands, thus competing with major complement regulators (factor H and FHL-1) for binding sites. In the eye, accumulation of FHR-4 is associated with increased complement activation and inflammation, implicated especially in the pathogenesis of age-related macular degeneration. Genetic variants of CFHR4 can alter systemic and local concentrations, influencing disease risk. The protein may also be involved in lipid metabolism and immune response, but its functions are primarily related to complement regulation and modulation.
Competes with complement factor H and FHL-1 for binding C3b, altering complement regulation. Facilitates complement activation and inflammation when dysregulated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement factor H-related protein 4 (CFHR4).